These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 2883685

  • 1. Low-dose zotepine in the maintenance treatment of schizophrenia.
    Fleischhacker WW, Stuppäck C, Barnas C, Unterweger B, Hinterhuber H.
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):61-3. PubMed ID: 2883685
    [Abstract] [Full Text] [Related]

  • 2. Zotepine in the treatment of negative symptoms in chronic schizophrenia.
    Fleischhacker WW, Barnas C, Stuppäck C, Unterweger B, Hinterhuber H.
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):58-60. PubMed ID: 2883684
    [Abstract] [Full Text] [Related]

  • 3. Results of an open phase II study with zotepine--a new neuroleptic compound.
    Fleischhacker WW, Unterweger B, Barnas C, Stuppäck C, Hinterhuber H.
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):64-6. PubMed ID: 2883686
    [Abstract] [Full Text] [Related]

  • 4. A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia.
    Cooper SJ, Tweed J, Raniwalla J, Butler A, Welch C.
    Acta Psychiatr Scand; 2000 Mar; 101(3):218-25. PubMed ID: 10721870
    [Abstract] [Full Text] [Related]

  • 5. Zotepine, a neuroleptic drug with a bipolar therapeutic profile.
    Dieterle DM, Ackenheil M, Müller-Spahn F, Kapfhammer HP.
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):52-7. PubMed ID: 2883683
    [Abstract] [Full Text] [Related]

  • 6. [Effectiveness of zotepine in therapy-refractory psychoses. An open, multicenter study in eight psychiatric clinics].
    Harada T, Otsuki S, Fujiwara Y.
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():41-4. PubMed ID: 1683339
    [Abstract] [Full Text] [Related]

  • 7. A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trial.
    Petit M, Raniwalla J, Tweed J, Leutenegger E, Dollfus S, Kelly F.
    Psychopharmacol Bull; 1996 Sep; 32(1):81-7. PubMed ID: 8927680
    [Abstract] [Full Text] [Related]

  • 8. [Zotepine: treatment of schizophrenic patients with predominantly negative symptoms. A double-blind study vs. haloperidol].
    Barnas C, Stuppäck CH, Miller C, Haring C, Sperner-Unterweger B, Fleischhacker WW.
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():36-40. PubMed ID: 1683338
    [Abstract] [Full Text] [Related]

  • 9. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
    Möller HJ, Riedel M, Müller N, Fischer W, Kohnen R.
    Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
    [Abstract] [Full Text] [Related]

  • 10. [Effectiveness and tolerance of zotepine in a double-blind comparison with perazine in schizophrenic patients].
    Dieterle DM, Müller-Spahn F, Ackenheil M.
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():18-22. PubMed ID: 1683334
    [Abstract] [Full Text] [Related]

  • 11. [Zotepine versus perazine in patients with paranoid schizophrenia: a double-blind controlled trial of its effectiveness].
    Wetzel H, von Bardeleben U, Holsboer F, Benkert O.
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():23-9. PubMed ID: 1683336
    [Abstract] [Full Text] [Related]

  • 12. Comparison of efficacy of zotepine and thiothixene in schizophrenia in a double-blind study.
    Sarai K, Okada M.
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):38-46. PubMed ID: 2883680
    [Abstract] [Full Text] [Related]

  • 13. Clinical experience with the neuroleptic zotepine--first results.
    Haug HJ.
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):35-7. PubMed ID: 2883679
    [Abstract] [Full Text] [Related]

  • 14. [Clinical effectiveness of zotepine in treatment of negative schizophrenic symptoms. Results of an open and a double-blind controlled trial].
    Müller-Spahn F, Dieterle D, Ackenheil M.
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():30-5. PubMed ID: 1683337
    [Abstract] [Full Text] [Related]

  • 15. Clinical and neuroendocrine effects of zotepine--a new neuroleptic drug.
    von Bardeleben U, Benkert O, Holsboer F.
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):28-34. PubMed ID: 2883678
    [Abstract] [Full Text] [Related]

  • 16. Switching from clozapine to zotepine in patients with schizophrenia: a 12-week prospective, randomized, rater blind, and parallel study.
    Lin CC, Chiu HJ, Chen JY, Liou YJ, Wang YC, Chen TT, Bai YM.
    J Clin Psychopharmacol; 2013 Apr; 33(2):211-4. PubMed ID: 23422395
    [Abstract] [Full Text] [Related]

  • 17. Clinical and EEG studies of zotepine, a thiepine neuroleptic, on schizophrenic patients.
    Higashi Y, Momotani Y, Suzuki E, Kaku T.
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):8-11. PubMed ID: 2883687
    [Abstract] [Full Text] [Related]

  • 18. [Double-blind comparison of 3 x 75 mg zotepine und 3 x 4 mg haloperidol in acute schizophrenic patients].
    Klieser E, Lehmann E, Tegeler J.
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():14-7. PubMed ID: 1683333
    [Abstract] [Full Text] [Related]

  • 19. [Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind study].
    Fleischhacker WW, Barnas C, Stuppäck CH, Sperner-Unterweger B, Miller C, Hinterhuber H.
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():10-3. PubMed ID: 1683332
    [Abstract] [Full Text] [Related]

  • 20. Profiles of clinical efficacy and pharmacological action of zotepine.
    Yamawaki S.
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):4-7. PubMed ID: 2883681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.